Related Experiment Video
Updated: Jul 9, 2026
10:45
Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling
Published on: May 31, 2017
Nanotechnology as an adjunct tool for transplanting engineered cells and tissues
Cesar V Borlongan1, Tadashi Masuda, Tiffany A Walker
1Department of Neurology, Medical College of Georgia, Augusta, GA 30904, USA. cborlongan@mail.mcg.edu
Current Molecular Medicine
|November 30, 2007
Summary
Nanotechnology offers innovative solutions for cell transplantation challenges, improving tissue engineering, gene therapy, and cell imaging for better disease treatment. This approach enhances cell integration and immune system compatibility, paving the way for advanced therapies.
Area of Science:
- Biotechnology and Nanomedicine
- Regenerative Medicine and Cell Therapy
Background:
- Cell transplantation shows promise for treating diseases like diabetes and spinal cord injury.
- Significant challenges hinder large-scale clinical trials, including universal cell sourcing, immune rejection, transplant integration, and in vivo monitoring.
Purpose of the Study:
- To review recent advancements in nanotechnology applications for cell transplantation.
- To highlight nanotechnology's role in overcoming current limitations in cell-based therapies.
Main Methods:
- Discussion of nanotechnology's capabilities in manipulating materials, tissues, and cells at the sub-micron level.
- Review of nanotechnology applications in tissue engineering, gene therapy, cell immunoisolation, and cell imaging.
Main Results:
- Nanotechnology provides tools to address key hurdles in cell transplantation.
- Innovations enable better control over cellular interactions, enhancing transplant efficacy and safety.
Conclusions:
- Nanotechnology is a crucial strategy for advancing cell transplantation therapies.
- Further integration of nanotechnology promises to improve outcomes in regenerative medicine and disease treatment.
